Clinical Trial

Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is * to better understand the dominant modes of transmission * to estimate the extent of transmission among contacts by determining the secondary infection rate for human-to-human transmission at an individual level and identifying factors associated with secondary infections. * to determine the proportion of asymptomatic or pauci-symptomatic infections. * to characterize the incubation period of mpox and the duration of infectiousness, including reproduction numbers. * to assess serological responses following confirmed infection.
Trial Details
NCT Number NCT07067723
Lead Sponsor Osaka Metropolitan University
Conditions Monkeypox (Mpox)
Enrollment 122 participants
Start Date 2024-08-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-16